USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE

The invention relates to the use of substituted 3-phenyl-5-alkoxy-1,3,4-oxdiazole-2-ones, in addition to their pharmacologically compatible salts and acid addition salts for producing medicaments, which exhibit an inhibiting action on pancreatic lipase, PL. The invention relates to the use of compounds of formula (I), in which the groups are defined as cited, in addition to their pharmacologically compatible salts and acid addition salts for producing a medicament for the prophylaxis or treatment of obesity or diabetes mellitus type 1 and 2.

Brüningstrasse 50, 65929 Frankfurt (DE). Germany

AVENTIS PHARMA DEUTSCHLAND GMBH

1891/CHENP/2004 A

1891/CHENP/2004

INDIA

2009-03-20T06:18:39Z

2007-07-20

2004-08-25

295808

2003-02-17

PCT/EP2003/001560

A61K 31/4152

WO/2003/072098

SCHOENAFINGER, Karl;, PETRY, Stefan;, MUELLER, Guenter;, BAUER, Armin, HEUER, Hubert, Otto

26695

380

Germany

2002-02-28

102 08 986.8

2007-07-20

USE OF SUBSTITUTED 3-PHENYL-5-ALKOXY-1,3,4-OXDIAZOLE-2-ONE FOR PRODUCING MEDICAMENTS THAT INHIBIT PANCREATIC LIPASE 3WkhH00

2009-04-30T18:36:42Z

61290 SCHOENAFINGER, KARL;, PETRY, STEFAN;, MUELLER, GUENTER;, BAUER, ARMIN, HEUER, HUBERT, OTTO 26156 AVENTIS PHARMA DEUTSCHLAND